Avita Medical Inc.
RCEL | NASDAQ
$11.61
+$0.77 (+7.10%)
Sep 22, 2026, 1:48 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Jun 29, 2021 |
|---|---|---|---|---|---|---|
Revenue | 71.61M | 64.25M | 50.14M | 34.42M | 33.03M | 29.23M |
Cost of Revenue | 12.79M | 9.09M | 7.78M | 6.04M | 6.1M | 5.95M |
Gross Profit | 58.82M | 55.16M | 42.36M | 28.38M | 26.92M | 23.28M |
Operating Income | -42.53M | -56.59M | -42.66M | -27.51M | -25.12M | -26.54M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -48.58M | -61.79M | -35.32M | -26.63M | -25.1M | -26.55M |
Net Income | -48.59M | -61.85M | -35.38M | -26.67M | -25.14M | -26.58M |
Selling & General & Admin | 80.51M | 91.39M | 65.63M | 45.24M | 37.21M | 37.06M |
Research & Development | 20.84M | 20.36M | 20.82M | 13.86M | 15.67M | 14.82M |
Other Expenses | n/a | n/a | -1.43M | -3.22M | -843K | -2.06M |
Operating Expenses | 101.35M | 111.75M | 85.02M | 55.89M | 52.04M | 49.82M |
Interest Expense | 5M | 5.36M | 1.14M | 16K | 29K | 33K |
Selling & Marketing Expenses | 53.14M | 58.2M | 37.29M | 21.91M | 16.27M | 14.66M |
Cost & Expenses | 114.14M | 120.84M | 92.8M | 61.93M | 58.14M | 55.77M |
Income Tax Expense | 11K | 54K | 66K | 36K | 42K | 38K |
Shares Outstanding (Basic) | 27.86M | 25.88M | 25.33M | 25M | 24.36M | 20.29M |
Shares Outstanding (Diluted) | 27.86M | 25.88M | 25.33M | 25M | 24.36M | 20.29M |
EPS (Basic) | -1.74 | -2.39 | -1.40 | -1.07 | -1.03 | -1.17 |
EPS (Diluted) | -1.74 | -2.39 | -1.40 | -1.07 | -1.03 | -1.17 |
EBITDA | -41.23M | -55.3M | -33.54M | -26.05M | -24.4M | -25.81M |
EBIT | -43.57M | -56.43M | -34.17M | -26.61M | -25.08M | -26.52M |
Depreciation & Amortization | 2.35M | 1.13M | 632K | 568K | 673K | 715K |
Add to Watchlist
Select watchlists to add or remove RCEL